Of note, TNFα neutralization was reported to improve insulin resistance in diabetic patients with rheumatoid arthritis or Crohn's disease who were also receiving anti-TNFα treatment (infliximab) for their autoimmune disease (Gupta-Ganguli et al, 2011). This evidence concerns the gene TNF and Insulin resistance.